Immune Modulatory Therapies LLC Profile last edited on: 1/24/20
CAGE: 7F0L2
UEI: J453G5R8UMJ5
Business Identifier: Therapies that modulate the body's immune system 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 27
County: Erie
Congr. District: 27
County: Erie
Public Profile
Immune Modulatory Therapies LLC is developing therapies that modulate the body's immune system. The firm's technologies reduce the body's immune response to specific tissues, thus reducing the effect of autoimmune diseases. The firm also is working on modulating the body's response to specific drugs, making these drugs less toxic and more effective over time.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2021 | 1 | NIH | $293,178 | |
| Project Title: Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine | ||||
| 2018 | 1 | NIH | $280,928 | |
| Project Title: Reversing/Blocking T Cell Suppression by Extracellular Vesicles as Cancer Therapy | ||||
Key People / Management
Maulasri Bhatta
Company News
There are no news available.
